CNIs are known to be associated with dyslipidemia by reducing Low-density lipoprotein – Cholesterol through interfering with the binding of LDL-C to its receptor and interfering with bile acid synthesis, which leads to LDL receptor downregulation (Agarwal and Prasad, 2016). Here, COG2 is linked to metabolic syndrome.